Skip to main content
PharmaBlock Sciences (Nanjing), Inc. logo

PharmaBlock Sciences (Nanjing), Inc. — Investor Relations & Filings

Ticker · 300725 ISIN · CNE1000035K5 Shenzhen Stock Exchange Manufacturing
Filings indexed 1,618 across all filing types
Latest filing 2023-12-25 Audit Report / Informat…
Country CN China
Listing Shenzhen Stock Exchange 300725

About PharmaBlock Sciences (Nanjing), Inc.

https://www.pharmablock.com

PharmaBlock Sciences (Nanjing), Inc. specializes in the design and manufacture of innovative building blocks and provides integrated chemistry services for drug discovery and development. The company offers a comprehensive portfolio of structurally diverse scaffolds and intermediates used to enhance the efficiency of medicinal chemistry. Its core capabilities include process research and development, scale-up production, and commercial-scale manufacturing under CDMO frameworks. By utilizing advanced chemical technologies and a vast library of unique chemical entities, the company supports global biotechnology and pharmaceutical organizations in streamlining their research pipelines and optimizing the transition from discovery to clinical development and commercialization.

Recent filings

Filing Released Lang Actions
关于审计机构变更签字会计师及项目质量控制复核人的公告
Audit Report / Information Classification · 95% confidence The document is an announcement regarding the change of the signing auditors and project quality control reviewers for the company's 2023 audit. It details the personnel changes in the audit firm assigned to the company and confirms that the change will not affect the 2023 financial audit work. The document does not contain any financial statements or audit results itself, but rather informs about the change in audit personnel. This fits the category of Audit Report / Information (AR), which includes standalone audit reports and related audit information excluding full annual reports. The document is not a full annual report (10-K), nor is it a regulatory filing or a report publication announcement. Therefore, the correct classification is AR with high confidence.
2023-12-25 Chinese
第三届董事会第二十七次会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at the 27th meeting of the 3rd Board of Directors of Nanjing Yaoshi Technology Co., Ltd. It includes voting results on various governance-related proposals such as amendments to the company charter, independent director work system, shareholder meeting rules, and committee work systems. It also announces the scheduling of a shareholders' meeting. The content focuses on board decisions and governance matters rather than financial results or audit reports. The document is not a full annual or interim report, nor is it a call transcript or earnings release. It is not a report publication announcement since it contains substantive meeting resolutions and voting outcomes. Therefore, the document fits best under the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the board of directors or senior management.
2023-12-13 Chinese
关联交易管理制度(2023年12月)
Governance Information Classification · 95% confidence The document is titled '南京药石科技股份有限公司 关联交易管理制度' which translates to 'Nanjing Yaoshi Technology Co., Ltd. Related Party Transaction Management System'. It is a detailed internal policy document outlining the principles, definitions, procedures, internal controls, and responsibilities related to related party transactions within the company. It references relevant laws and regulations such as the Company Law of the People's Republic of China, Securities Law, and Shenzhen Stock Exchange rules. The document is a governance-related internal control policy rather than a financial report, announcement, or regulatory filing. It does not contain financial statements, earnings data, voting results, or management changes. It is a governance practice document detailing internal rules and procedures for related party transactions, which fits the definition of Governance Information (CGR). The document length (6468 characters) and content confirm it is a full policy document, not a brief announcement or certification. Therefore, the appropriate classification is CGR with high confidence.
2023-12-13 Chinese
独立董事专门会议工作制度(2023年12月)
Governance Information Classification · 95% confidence The document is a detailed internal governance policy specifically about the procedures and rules for independent directors' special meetings at 南京药石科技股份有限公司. It references laws and regulations related to corporate governance and independent directors but does not contain financial data, audit results, or any report on financial performance. It is a governance-related document outlining internal rules and procedures rather than a report or announcement of financial results or corporate actions. Therefore, it fits best under Governance Information (CGR). The document length is short and focused on governance rules, not a report publication or regulatory filing.
2023-12-13 Chinese
股东大会议事规则(2023年12月)
Governance Information Classification · 95% confidence The document is titled "股东大会议事规则" which translates to "Rules of Procedure for the Shareholders' General Meeting" of 南京药石科技股份有限公司. It extensively details the procedures, rights, responsibilities, and regulations governing the conduct of shareholders' meetings, including the calling, notification, voting, and execution of resolutions. It does not contain financial statements, audit opinions, or earnings data. Instead, it focuses on governance and procedural rules related to the shareholders' meetings. This aligns with the category of Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices. The document is lengthy (13,796 characters) and comprehensive, indicating it is the actual governance document, not merely an announcement or summary. Therefore, the appropriate classification is CGR with high confidence.
2023-12-13 Chinese
公司章程修订对照表(2023年12月)
Governance Information Classification · 100% confidence The document is a detailed comparison table showing amendments to the company's Articles of Association (章程修订对照表), which is a governance document outlining the company's internal rules, board structure, and governance practices. The content focuses on changes to board and committee structures, director qualifications, and governance procedures. There is no indication of financial data, audit results, or regulatory filings. The document is not an announcement of a report but the actual text of governance rule changes. Therefore, the document fits the category of Governance Information (CGR).
2023-12-13 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.